4-Methylmorpholine → HCID 86718195, compound

HRID 1844204Notes

Reaction equation

HRID 1844204 reaction equation
CN(C(O[N:9]1N=N[C:11]2C=CC=[CH:15][C:10]1=2)=[N+](C)C)C.[B-](F)(F)(F)F.CN1CC[O:27]CC1.[CH:30]1([CH2:36][O:37][C:38]2[C:39]3[N:40]([C:44]([C:49]([OH:51])=O)=[C:45]([CH2:47][CH3:48])[N:46]=3)[CH:41]=[CH:42][CH:43]=2)[CH2:35][CH2:34][CH2:33][CH2:32][CH2:31]1>CS(C)=O>[CH:30]1([CH2:36][O:37][C:38]2[C:39]3[N:40]([C:44]([C:49]([NH:9][C@H:10]([CH3:11])[CH2:15][OH:27])=[O:51])=[C:45]([CH2:47][CH3:48])[N:46]=3)[CH:41]=[CH:42][CH:43]=2)[CH2:31][CH2:32][CH2:33][CH2:34][CH2:35]1

Participants

5

Procedure

3.3 mg (0.044 mmol) of L-alaminol, 14 mg (0.044 mmol) of TBTU and 20 mg (0.198 mmol) of N-methylmorpholine were added to a solution of 12 mg (0.040 mmol) of 8-(cyclohexylmethoxy)-2-ethylimidazo[1,2-a]pyridine-3-carboxylic acid in 750 μl of DMSO, and the mixture was then shaken at room temperature overnight. The mixture was then purified by preparative HPLC (Method 6), giving 12 mg (84% of theory) of 8-(cyclohexylmethoxy)-2-ethyl-N-[(2R)-1-hydroxypropan-2-yl]imidazo[1,2-a]pyridine-3-carboxamide as formic acid salt.

Workup

  1. customThe mixture was then purified by preparative HPLC (Method 6)

Sources & evidence

ORD record
ord-ee9eda6546d14a459b406abcdcd4ef58
Source dataset
uspto-grants-2015_02
Patent number
US08946215B2

Reaction notes

Loading…